All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo
2016
FMS-like tyrosine kinase 3 (FLT3)-mutant acute myeloid leukemia (AML) portends a poor prognosis, and ineffective targeting of the leukemic stem cell (LSC) population remains one of several obstacles in treating this disease. All- trans retinoic acid (ATRA) has been used in several clinical trials
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
43
References
34
Citations
NaN
KQI